0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Feb 23, 2017 - MedWatch Drug Updates

Recall of XtraHRD Natural Male Enhancement Capsules by Organic Herbal Supply - Contains undeclared drug ingredients

Recall of XtraHRD Natural Male Enhancement by Organic Herbal Supply as it was found to contain undeclared tadalafil

Read more
  • Feb 16, 2017 - FDA Drug Updates

FDA approves Siliq (brodalumab) for psoriasis

Siliq (brodalumab) is indicated in patients who are candidates for systemic therapy or phototherapy

Read more
  • Feb 15, 2017 - FDA Drug Updates

FDA approved Parsabiv (etelcalcetide) for hyperparathyroidism in dialysis patients

Parsabiv (etelcalcetide) can be administered intravenously at the end of the hemodialysis session

Read more
  • Feb 10, 2017 - FDA Drug Updates

FDA approval of Emflaza (deflazacort) for duchenne muscular dystrophy

FDA approved Emflaza (deflazacort) for duchenne muscular dystrophy in >=5 years old patients

Read more
  • Feb 16, 2017 - MedWatch Drug Updates

Recall of Human chorionic gonadotropin freeze dried vials by Synergy Rx – Lack of sterility assurance

Synergy Rx Pharmacy recalled the Human chorionic gonadotropin (HCG) 5,000 and 11,000 units/vial due to a lack of sterility assurance

Read more
  • Jan 20, 2017 - FDA Drug Updates

Approval of Trulance (plecanatide) for chronic idiopathic constipation

FDA approved Trulance (plecanatide) for chronic idiopathic constipation in adults

Read more
  • Feb 10, 2017 - MedWatch Drug Updates

Recall of Well Balance Xanthium & Siler Combo dietary supplement by Kingsway - Contains banned ephedra alkaloids

Kingsway Trading has initiated the recall of Well Balance Xanthium & Siler Combo dietary supplement due to the presence of undeclared ephedra alkaloids

Read more
  • Feb 10, 2017 - MedWatch Drug Updates

Recall of Ibuprofen lysine injection, 20 mg /2 mL by Exela Pharma Sciences – Presence of particulate matter

Exela Pharma Sciences recalled Ibuprofen lysine injection, 20 mg /2 mL (10 mg/mL) due to the presence of particulate matter

Read more
  • Feb 10, 2017 - MedWatch Drug Updates

Class I Recall of Alaris Syringe Pump Module by CareFusion – Faulty sensor may generate false alarm

CareFusion is recalling the Alaris Syringe Pump because of faulty Air-In-Line (AIL) sensor which may generate a false alarm

Read more
  • Feb 3, 2017 - MedWatch Drug Updates

Chlorhexidine gluconate - Rare but serious allergic reactions have been reported

FDA has warned that rare but serious allergic reactions have been reported with the use of chlorhexidine gluconate

Read more